New partnership helps clinicians gain access to expanded clinical insights without leaving the app they already trust

epocrates, a leading digital platform for clinicians, today announced a partnership with Glass Health, a premier clinical AI platform for clinical decision support and ambient scribing, to expand clinical decision support within AI Assist, its conversational AI capability. AI Assist helps clinicians explore clinical questions, find relevant information, and consider meaningful follow-ups within the epocrates app. By bringing Glass Health’s clinical frontier model, Glass, into epocrates AI Assist, the partnership combines nearly 30 years of epocrates’ experience supporting clinicians with Glass Health’s expertise in clinical AI, giving clinicians access to drug information and broader clinical insights in one conversational experience.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261112783944/en/

epocrates selected Glass Health following an extensive evaluation of several potential clinical AI partners. Its clinical and medical information team, including physicians and pharmacists, determined Glass Health was the right strategic partner, as it reflects a shared view that clinical AI should earn clinicians’ trust through the quality of its answers, the evidence supporting them, and its usefulness in everyday care. epocrates brings decades of drug information expertise and experience serving clinicians at the point of care. Glass Health brings expertise in developing and evaluating AI for clinical decision support.

“Clinicians have trusted epocrates for drug information for nearly 30 years, and that trust comes from getting the details right,” said David Minkin, President and General Manager of epocrates. “As clinicians bring broader questions to AI Assist, we wanted a partner held to the same standard. As we evaluated our options, Glass Health stood out for the quality of its answers and the evidence behind them. This partnership is another step in our ongoing investment in trusted, reliable answers clinicians can act on.”

epocrates took a deliberate approach to developing AI Assist, working directly with clinicians throughout research and testing to understand their needs and refine the experience. Clinician feedback and careful evaluation helped guide development, reflecting the same priority that shaped partner selection: upholding the standards of quality and reliability clinicians expect from epocrates. Glass Health was selected for the clinical accuracy, quality, and usefulness of its answers, the sources it draws on, its performance on independent benchmarks against other clinical decision support tools, and how well it works within AI Assist.

“The future of clinical AI is integrating state-of-the-art technology with the best available evidence,” said Dereck Paul, MD, co-founder and CEO of Glass Health. “Clinicians have relied on epocrates for decades because of its commitment to accuracy and the quality of its clinical information. AI Assist reflects that same standard. We're proud that Glass Health's technology is helping power it, so clinicians can get relevant, evidence-based answers inside the app they already trust every day.”

AI Assist, including Glass Health clinical decision support, is available to epocrates+ users and will be rolling out to all users in the coming weeks. It will remain in beta as the rollout continues.

About epocrates
Since 1998, epocrates, an athenahealth, Inc. company, has built a legacy of clinical trust and today serves more than one million clinicians* seeking fast, reliable answers at the point of care. With unparalleled prescribing and safety information, the epocrates app enables fast, reliable answers at the point of care—empowering physicians, nurses, pharmacists, and other healthcare professionals to deliver more effective and personalized patient care. Learn more at www.epocrates.com/discover.
* epocrates analytics 2026

About Glass Health
Glass Health builds a leading clinical AI platform for clinicians and healthcare technology companies. Its clinical AI agent analyzes patient context alongside the world’s medical literature to help clinicians answer questions, reason through complex cases, and develop evidence-based treatment plans. Glass demonstrated leading performance in clinical reasoning on the ARISE Network’s Medical AI Superintelligence Test. Glass empowers clinicians worldwide with a platform for clinical decision support and ambient scribing, and gives developers access to that same clinical intelligence through the Glass Developer API to build the next generation of healthcare technology. Learn more at glass.health

View source version on businesswire.com: https://www.businesswire.com/news/home/20261112783944/en/

AI should earn clinicians’ trust through the quality of its answers, the evidence supporting them, and its usefulness in everyday care.